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AbstrAct
Objective To determine prevalence and factors predictive 
of periodontitis by using a standardized assessment model 
in adults with type 2 diabetes.
Research design and methods We performed an 
observational cross-sectional study to determine the 
burden of periodontitis in adults with type 2 diabetes 
attending urban, ambulatory referral centers in the 
USA and UK. Full-mouth probing was performed and 
periodontitis was diagnosed based on either a low (≥5 mm 
at ≥1 site) or high pocket probing-depth threshold (≥6 mm 
at ≥1 site). Results were stratified into a five-stage schema 
and integrated with other clinical variables into the 
novel Diabetes Cross-Disciplinary Index to function as a 
balanced health scorecard. Corresponding demographic 
and routinely collected health data were obtained and 
comparisons were made between patients with and 
without periodontitis. Multivariable logistic regression was 
performed to identify factors predictive of the presence or 
absence of periodontitis.
Results Between our two cohorts, 253 patients were 
screened. Caucasians comprised >90% and Hispanic 
Americans >75% of the UK and US cohorts, respectively. 
Males and females were equally distributed; mean age 
was 53.6±11 years; and 17 (6.7%) were edentulous. Of 
the 236 dentate patients, 128 (54.2%) had periodontitis 
by low threshold and 57 (24.2%) by high threshold. Just 
17 (7.2%) were periodontally healthy. No significant 
differences in age, HbA1c, blood pressure, body mass 
index, low-density lipoprotein cholesterol, or smoking 
status (all p>0.05) were identified between those with or 
without periodontitis (regardless of threshold) and none 
was found to be a significant predictor of disease.
Conclusions Periodontitis is frequent in adults with 
type 2 diabetes and all should be screened. Periodontal 
health status can be visualized with other comorbidities 
and complications using a novel balanced scorecard that 
could facilitate patient–clinician communication, shared 
decision-making, and prioritization of individual healthcare 
needs.
IntroductIon
People with type 2 diabetes are at higher risk 
of developing a number of disabling and 
life-threatening comorbidities and compli-
cations, including periodontal disease, than 
people without diabetes.1 The type 2 diabetes 
pandemic and its consequences result from 
complex interactions of genetic and epigen-
etic systems within complex social structures 
that include many behavioral and environ-
mental factors.2 3 The relationship between 
type 2 diabetes and periodontitis has been 
extensively investigated.4–7 Poor glucose 
control poses an increased risk of inflam-
mation of the tissue surrounding the tooth 
(periodontium), which is a major cause of 
tooth loss, increased risk of cardiovascular 
disease, and death.1 4 7 8 Conversely, inflam-
mation can exacerbate insulin resistance and 
poor glycemic control.3 Timely detection 
and management of comorbid periodontal 
disease in people with type 2 diabetes could 
optimize oral hygiene, prevent tooth loss, 
facilitate a healthy diet, and improve glucose 
control.1 7 9
Global prevalence of type 2 diabetes is 
increasing and three in four affected adults 
now live in low-and-middle-income coun-
tries, which means that without effective 
screening and management strategies rates 
of oral and systemic health complications are 
likely to increase.1 Assessing the status of peri-
odontal health is a standard recommendation 
for delivering integrated, ‘whole-person’ 
diabetes care10–12 in the USA and elsewhere,1 
yet fewer than half of American adults with 
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known diabetes have annual dental examinations.13 In 
the UK, despite 15 Healthcare Essentials that comprise 
the most recent guidelines for care for everyone with 
diabetes published by Diabetes UK, periodontal health 
is not included and there is no recommendation to seek 
oral health evaluation.14 Barriers to care integration 
include the lack of patient and provider awareness of the 
relationship between oral and general health15 as well as 
the lack of electronic record-linkage and data-sharing 
between medical and dental providers.16 Furthermore, 
variation between national guidelines based on single 
conditions and the challenges of managing patients with 
multimorbidity likely contribute to clinical inertia that 
could hinder the integration of oral and systemic health 
and care.17–21
Diagnostic thresholds for periodontitis have been 
debated extensively in the periodontal literature and 
there is no global consensus.22–24 Despite variations in 
diagnostic criteria,22 25 26 one in nine adults is estimated to 
have advanced (severe) periodontitis26 and people with 
type 2 diabetes are at an up to threefold increased risk, 
particularly if glycemic control is poor.7 Apart from the 
suggestion that Hispanic Americans may be, in contrast 
to other racial and ethnic groups, disproportionately 
affected with periodontitis, the true burden and clinical 
characteristics of periodontal disease across different 
adult populations with type 2 diabetes remain largely 
unknown.25 27 Indeed, genetic and population diversity, 
which has been suggested to underpin the phenotypic 
heterogeneity of diabetic complications,28 29 is likely to 
be of significant importance for the delivery of precision 
healthcare.30
We, therefore, decided to (1) devise a simplified and 
standardized diagnostic screening schema to determine 
the prevalence of periodontitis in our two geographi-
cally and demographically disparate cohorts; (2) identify 
clinical variables that could reliably predict the pres-
ence or absence of periodontal disease in individual 
adults with type 2 diabetes; and (3) introduce, at one 
of our centers, a novel, cross-disciplinary ‘balanced 
health scorecard’ designed to capture a ‘whole-person’ 
view of the complexity and severity of comorbidities 
and complications, including periodontal disease, and 
promote patient–clinician communication, shared deci-
sion-making, patient engagement and adherence, and 
improved patient-centered health outcomes.
reseArch desIgn And methods
We undertook a registry-supported, observational 
cross-sectional cohort study of patients aged ≥18 years 
who were receiving care at two urban diabetes referral 
centers, the Western Diabetes Institute (WDI) at Western 
University of Health Sciences, Pomona, California, 
USA, and Newcastle upon Tyne Hospitals and Newcastle 
University (NCL), Newcastle upon Tyne, UK. Full-mouth 
periodontal assessment by dental care teams at their 
respective institutions was performed to screen for peri-
odontitis. All patients gave written, informed consent 
prior to participating in the research, which was under-
taken following receipt of appropriate ethical approvals.
Between September 2014 and June 2016, patients 
at WDI underwent periodontal screening as part of a 
multidisciplinary, ‘one-stop-shop’ evaluation within an 
urban, ambulatory, integrated practice unit setting,31 
and additionally gave permission to have their past, 
present, and future health record information placed 
into the IRB-approved WDI Diabetes Research Registry. 
Following the evaluation, patient data were entered into 
the novel Diabetes Cross-Disciplinary Index (DXDI) 
(figure 1). DXDI plots the clinical status of 13 diabe-
tes-relevant health domains as a ‘balanced scorecard’.32 
Each domain is stratified into levels 1 (health/absence 
of disease) through 5 (advanced disease). The domains 
encompass essential components of a comprehensive 
diabetes evaluation,10 including glycemic, cholesterol 
and blood pressure control; the status of kidney health, 
significance of this study
What is already known about this subject?
 ► Adults with type 2 diabetes and its inherent complexity, phenotypic 
heterogeneity, and frequent multimorbidities are at increased risk 
of periodontitis yet there is no consensus on international standards 
for its diagnosis or strategies for screening.
 ► Barriers to providing integrated and team-based cross-disciplinary 
care for adults with type 2 diabetes that is required for optimizing 
patient-centered health outcomes include the lack of patient and 
provider awareness of the relationship between oral and general 
health; inconsistent health messaging across all healthcare 
providers involved in a patient’s longitudinal care; and the lack of 
effective communication and data-sharing between medical and 
dental providers.
What are the new findings?
 ► Our simplified approach to periodontal screening and staging of all 
adults with type 2 diabetes involves full-mouth periodontal probing, 
without the need for radiographs, and could be undertaken by either 
dentists, dental hygienists, or therapists and facilitate replication 
and scale-up in both resource-rich and resource-challenged 
locations around the globe.
 ► Results of standardized periodontal health screening in adults 
with type 2 diabetes can be visually integrated with other relevant 
clinical findings into a balanced health scorecard, such as the 
Diabetes Cross-Disciplinary Index (DXDI), to aid in patient–clinician 
communication and multidisciplinary management of comorbid 
chronic diseases.
How might these results change the focus of research or 
clinical practice?
 ► Integrating periodontal health status into standard comprehensive 
evaluations for all adults with type 2 diabetes can be effectively 
undertaken.
 ► Balanced health scorecards such as the DXDI that integrate oral and 
general health require additional field-testing to determine whether 
patient–provider communication could be optimized, patient-
centered outcomes improved, and if diabetes care guidelines and 
policy decisions should be modified.
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Figure 1 The Diabetes Cross-Disciplinary Index (DXDI). The DXDI is a pictorial representation of diabetes-relevant health 
domains, including glycemic control (HbA1c), low-density lipoprotein cholesterol (LDLc) level, systolic blood pressure (SBP), 
and diastolic blood pressure (DBP); kidney health (urinary albumin-to-creatinine ratio (UACR) and estimated glomerular 
filtration rate (eGFR)), retinal health (dilated retinal scan), periodontal health (see below), foot health, functional independence 
measure; as well as body mass index (BMI), waist circumference (WC), depression (patient health questionnaire 9 (PHQ 9)), 
and smoking status. Each domain is stratified into levels 1 (ie, health or absence of disease) through 5 (ie, severe or advanced 
disease). Periodontal health status was stratified in the following manner: 1, periodontal health (probing depths (PD) ≤3 mm 
and bleeding on probing (BOP) ≤15% of sites); 2, gingivitis/incipient periodontitis (PD ≤4 mm and/or BOP >15% of sites); 
3, mild–moderate periodontitis (PD=5 mm at ≥1 site); 4, localized advanced periodontitis (PD ≥6 mm at ≤30% sites); and 
5, generalized advanced periodontitis (PD ≥6 mm at >30% sites). CVD, cardiovascular disease; PVD, peripheral vascular 
disease.
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retinal health, foot health, and functional independency; 
general and central adiposity measurements; as well as a 
depression screen and an assessment of smoking status.
At the time of our study, there was no consensus on 
international standards for reporting periodontitis prev-
alence, extent, and severity.22 Therefore, periodontal 
assessment in dentate patients included the extent of 
full-mouth, pocket-probing depth (PD) measurements 
and bleeding on probing (BOP). Periodontal health 
status was stratified in the following manner: DXDI 1, 
periodontal health (PD ≤3 mm and BOP ≤15% of sites); 
DXDI 2, gingivitis/incipient periodontitis (PD ≤4 mm 
and/or BOP >15% of sites); DXDI 3, mild–moderate 
periodontitis (PD=5 mm at ≥1 site); DXDI 4, localized 
advanced periodontitis (PD ≥6 mm at ≤30% sites); and 
DXDI 5, generalized advanced periodontitis (PD ≥6 mm 
at >30% sites). For the purpose of regression analyses, 
patients were also assigned to categories of either ‘no 
periodontitis’ (corresponding to DXDI scores 1 or 2) or 
‘periodontitis’ that was further stratified by using either 
a low threshold (PD ≥5 mm at ≥1 site, corresponding to 
DXDI score 3) or a higher threshold (PD ≥6 mm at ≥1 site, 
corresponding to DXDI scores 4 or 5) to define presence 
of periodontitis.
Patients at the NCL between January 2007 and 
December 2009 were being primarily managed in the 
diabetes clinic and underwent screening for periodontal 
disease at the Newcastle Dental Hospital. Demographic 
and clinical data of NCL patients were extracted via 
retrospective chart review and corresponded to the time 
of periodontal screening. In addition to periodontal 
health status, data that were evaluable and common 
to both WDI and NCL cohorts included age, gender, 
ethnicity, smoking status, glycated hemoglobin, systolic 
and diastolic blood pressure, body mass index (BMI), 
and low-density lipoprotein cholesterol (LDLc).
Statistical analyses were conducted using SAS software 
for Windows V.9.3. Descriptive statistics were presented as 
means and SD for continuous variables, and frequencies 
and proportions for categorical variables. Independent 
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Table 1 Comparisons of recorded parameters in the ‘periodontitis’ and ‘no periodontitis’ groups 
Low threshold for periodontitis
(PD ≥5 mm at ≥1 site)
High threshold for periodontitis
(PD ≥6 mm at ≥1 site)
Periodontitis 
n=128 
(54.2%)
No periodontitis 
n=108
(46.8%) p Value
Periodontitis 
n=57
(24.2%)
No periodontitis 
n=179
(75.8%) p Value
Age (years) 52.7±9.3 53.3±12.2 0.679 52.5±8.3 53.1±11.4 0.682
HbA1c (%) 8.2±1.8 7.9±1.8 0.679 8.1±1.8 8.1±1.9 0.949
HbA1c (mmol/mol) 66.1±20.1 63.1±20.2 0.260 64.5±19.9 64.8±20.3 0.686
Systolic blood pressure (mm Hg) 139.3±21.2 138.2±20.8 0.689 140.6±21.3 138.2±20.9 0.442
Diastolic blood pressure (mm Hg) 82.2±15.9 80.6±10.4 0.355 83.2±16.1 81.0±12.8 0.343
Body mass index (kg/m2) 33.7±7.3 34.8±8.3 0.258 34.4±6.0 34.1±8.3 0.811
Low-density lipoprotein cholesterol 
(mg/dL)
126.7±36.6 128.5±43.1 0.838 125.7±36.5 128.4±41.0 0.778
Current smoker, n (%) 12 (9.4%) 4 (3.7%) 0.047 5 (8.8%) 11 (6.1%) 0.127
Former smoker, n (%) 49 (38.3%) 32 (29.6%) 25 (43.9%) 56 (31.3%)
Never smoked, n (%) 67 (52.3%) 72 (66.7%) 27 (47.4%) 112 (62.6%)
Values expressed as means ± SD for continuous variables and n (%) for categorical variables. No significant differences were identified (all 
p>0.05) for comparisons between groups within low and high thresholds for defining periodontitis. 
PD, probing depth measurements.
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samples t-tests were used to assess significance of differ-
ences for continuous variables between the periodontitis 
and no periodontitis groups, and χ2 tests to compare cate-
gorical variables between groups. Multivariable logistic 
regression was performed to identify factors associated 
with the presence of periodontitis, and analysis of vari-
ance was used to compare continuous variables common 
to the combined WDI and NCL cohort according to peri-
odontal DXDI score.
results
Across the two centers, a total of 253 patients with previ-
ously diagnosed type 2 diabetes (170 at WDI and 83 at 
NCL) underwent full-mouth periodontal assessment. 
Hispanic Americans comprised >75% of the WDI cohort, 
whereas white Caucasians comprised 94% of the NCL 
cohort. The combined study population contained 
roughly equal numbers of males and females (125 and 
128, respectively) and the mean age was 53.6±11 years. 
A total of 146 (57.7%) reported never having smoked 
tobacco, and of the 107 who reported using tobacco 
at some point in their lives, 17 (15.9%) were currently 
smokers.
In total, 17 (6.7%) of the 253 screened were edentu-
lous. Of the remaining 236 dentate patients, 128 (54.2%) 
were assigned a diagnosis of periodontitis based on the 
low threshold and 57 (24.2%) were diagnosed based 
on the higher threshold for periodontitis (table 1). 
No significant differences were identified between the 
‘periodontitis’ and ‘no periodontitis’ groups (within 
thresholds) for age, smoking status, BMI, blood pressure, 
LDLc, or HbA1c (all p>0.05), and none of these factors 
was identified as a significant predictor for the presence 
of periodontitis in multivariable logistic regression.
Furthermore, there were no significant differences 
between periodontal DXDI classifications with respect to 
evaluable clinical variables that were common to both the 
WDI and NCL cohorts (table 2). Table 2 also identifies 
that of the 236 dentate patients in our combined cohort 
only 17 (7.2%) were periodontally healthy.
conclusIons
The emerging global burden of comorbid type 2 diabetes 
and periodontal disease is likely to have significant 
impact on quality and longevity of life for hundreds of 
millions of people well into the 21st century. Given the 
geographically and demographically disproportionate 
burden of these complex, chronic diseases that are, in 
turn, challenged by anachronistic healthcare systems and 
conflicting clinical guidelines,1 10 14 patients are frequently 
not informed of their increased risk for periodontitis and 
the importance of its management to optimize oral and 
general health. As a result, many affected adults with type 
2 diabetes fall short of achieving goals for preventive prac-
tices like dental examinations,13 which further obscures 
the true burden of multimorbidity on the population. 
Indeed, novel screening and management strategies 
are desperately needed and, to be truly impactful, must 
involve practical, replicable, and scalable solutions.
In our multicenter study, respectively representative 
of predominantly Hispanic American and white Cauca-
sian British patients with type 2 diabetes, we observed 
epidemic rates of periodontitis whether using a low 
(54.2%) or high (24.2%) diagnostic threshold to define 
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Table 2 Evaluable clinical variables common to both Western Diabetes Institute and Newcastle University cohorts according 
to periodontal Diabetes Cross-Disciplinary Index (DXDI) classification
Periodontal 
DXDI 1
(n=17)
Periodontal 
DXDI 2 
(n=91)
Periodontal 
DXDI 3 
(n=71)
Periodontal 
DXDI 4
(n=57) p Value
Age (years) 57.7±15.5 52.4±11.3 52.8±10.2 52.5±8.3 0.300
HbA1c (%) 7.7±1.7 8.0±1.9 8.3±1.9 8.2±2.0 0.531
HbA1c (mmol/mol) 60.2±18.5 63.7±20.5 67.2±20.2 65.7±19.9 0.519
Systolic blood pressure (mm Hg) 144.1±16.7 137.2±21.3 138.2±21.2 140.7±21.3 0.560
Diastolic blood pressure (mm Hg) 81.4±11.9 80.5±10.2 81.5±15.8 83.2±16.1 0.714
Body mass index (kg/m2) 35.0±8.1 34.8±8.4 33.1±8.2 34.4±6.0 0.542
Low-density lipoprotein cholesterol (mg/dL) 139.2±38.2 125.1±44.7 128.2±37.9 125.7±36.5 0.841
Current smoker 0 (0%) 4 (4.4%) 7 (9.9%) 5 (8.8%) 0.142
Former smoker 3 (17.7%) 29 (31.9%) 24 (33.8%) 25 (43.9%)
Never smoked 14 (82.4%) 58 (63.7%) 40 (56.3%) 27 (47.4%)
None was classified as periodontal DXDI 5 in either cohort. Values expressed as means ± SD for continuous variables and n (%) for 
categorical variables.
Periodontal health status stratification:  DXDI 1, periodontal health (PD ≤3 mm and BOP ≤15% of sites); DXDI 2, gingivitis/incipient 
periodontitis (PD ≤4 mm and/or BOP >15% of sites); DXDI 3, mild-moderate periodontitis (PD=5 mm at ≥1 site); DXDI 4, localized advanced 
periodontitis (PD ≥6 mm at ≤30% sites); DXDI 5, generalized advanced periodontitis (PD ≥6 mm at >30% sites).
BOP, bleeding on probing; PD, probing depth. 
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the presence of disease. However, we were unable to 
identify, through multivariable logistic regression, any 
clinical predictors of periodontitis. Therefore, we concur 
with published guidelines that recommend periodontal 
screening (as an essential part of comprehensive health 
evaluation and management) for all adults with type 2 
diabetes. Our simplified approach to screening with full-
mouth periodontal probing (and not requiring the use 
of radiographs) could be undertaken by either dentists 
or task-shifted to dental hygienists and therapists.33 Such 
an approach could facilitate the periodontal assess-
ment of patients with diabetes in both resource-rich and 
resource-challenged locations,2 and is supported by the 
European Federation of Periodontology manifesto on 
periodontal diseases and general health, which ‘calls 
upon all dental and health professionals to act in the 
prevention, early diagnosis and effective treatment of 
periodontal disease to combat the devastating oral and 
general health effects for the individual and society’.34
Integrated and cross-disciplinary approaches that 
reorganize provider teams around patients are required 
for successful management of type 2 diabetes with its 
inherent complexity, phenotypic heterogeneity, and 
frequent multimorbidities.2 10 28 31 Integrating proper 
prevention and treatment of periodontitis may lower the 
risk of long-term diabetic complications.7 9 Systematic 
incorporation of standardized periodontal screening 
into routine diabetes care is a practical first step toward 
such integration. Management strategies that employ 
shared decision-making tools,35 36 such as a balanced 
health scorecard32 like DXDI, help all stakeholders to 
visualize the relevant yet disparate domains, gauge prog-
ress, and provide periodic feedback, could prove to 
activate, motivate, and incentivize patients to pursue any 
needed behavioral and lifestyle changes. Balanced score-
cards32 have emerged in multiple sectors, including large 
healthcare organizations, to more appropriately assess 
performance in highly specific and complex multidimen-
sional systems. Shared decision-making aids that include 
condition-specific educational materials have been deter-
mined to have beneficial effects on health behavior and 
health status of patients facing health treatments and 
screening decisions as well as to promote patient-centered-
ness among clinicians providing specialty consultations 
and complex interventions.35 36
Many patients express a desire that all their care 
providers offer consistent health messaging and facilitate 
access to the care that they need. Yet patients perceive 
that a division exists between the medical and dental 
professions, which has the potential to negatively impact 
on diabetes care.15 At one of our centers (WDI), bridges 
were built across multiple interprofessional divides. Peri-
odontal data are integrated into the balanced health 
scorecard, DXDI (figure 1), to promote precision health-
care for people with diabetes. Periodontal health status 
is stratified in the following manner: 1, periodontal 
health (PD ≤3 mm and BOP ≤15% of sites); 2, gingivitis/
incipient periodontitis (PD ≤4 mm and/or BOP >15% 
of sites); 3, mild–moderate periodontitis (PD=5 mm 
at ≥1 site); 4, localized advanced periodontitis (PD ≥6 mm 
at ≤30% sites); and 5, generalized advanced periodontitis 
(PD ≥6 mm at >30% sites). Other DXDI domains incorpo-
rate validated staging criteria for their respective aspects 
of health and disease. For example, the DXDI domain 
for kidney health reflects contemporary approaches to 
chronic kidney disease staging.37 Adiposity was derived 
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from established BMI and waist circumference ranges.38 
The diabetic foot staging, originally based on the Univer-
sity of Texas classification system,39 was further modified 
to conform with subsequent work published by the Scot-
tish Diabetes Foot Action Group.40 Retinopathy staging 
was based on international clinical severity scales41 and 
functional status was adapted from the validated Func-
tional Independence Measure.42
Facilitating appropriate dental referrals for those found 
to have periodontitis through standardized screening 
is just a start. Diabetes self-management education and 
support emphasizes the interrelationship of proper nutri-
tion, oral health self-care, and regular physical activity. For 
example, at WDI the hygienist and dietitian-nutritionist 
can identify barriers and collaborate with the patient to 
devise an individualized meal plan that accounts for their 
oral health status, including the presence of any loose 
teeth and objective evidence of periodontitis as well as 
any complaints of sore gums and painful chewing. The 
hygienist, nutritionist, and physical therapist, often on 
the same follow-up appointment day, can work in concert 
with each patient to combine activities and behavioral 
management strategies.
However, there are several limitations of this study that 
warrant consideration when interpreting the results. 
While all attempts were made to standardize periodontal 
assessments with simplified and reproducible, quantita-
tive criteria, the lack of universally agreed upon standards 
for diagnosing the presence, extent, and severity of peri-
odontitis raises the possibility that its true prevalence was 
either overestimated or underestimated in our study. 
Second, while we were able to control for thoroughness 
and reliability of periodontal screening data at both WDI 
and NCL, the need to retrieve historical chart data for 
other corresponding clinical variables for the patient 
group at NCL could have affected our multivariable anal-
ysis, therefore limiting our ability to identify factors that 
were significantly associated with the presence of peri-
odontitis. Finally, our study was not designed to assess the 
utility and impact of DXDI. Although anecdotal feedback 
from clinicians and patients suggested that DXDI could 
aid patient–clinician communication and engagement 
over time, this remains to be proven.
Therefore, more research is now required to investi-
gate several remaining open questions. First, the impact 
of DXDI on the health outcomes of patients with type 2 
diabetes and its associated comorbidities and complica-
tions remains to be defined. It seems intuitive that the 
ranking and visualization of multiple diabetes-relevant 
health domains would enable team-based discussion 
around the sequencing and prioritization of care for each 
patient.43 Yet, it would be important to know if DXDI 
helps providers from multiple disciplines to communicate 
consistent messaging to patients and improve their access 
to oral healthcare.15 Furthermore, while DXDI provides a 
composite view of the complexity and severity of diabetes 
and multimorbidity in our particular study population, its 
applicability to other ethnic, racial, and cultural groups 
would require additional field-testing and pilot-testing 
to determine whether it optimizes communication and 
facilitates the delivery of improved patient-centered 
outcomes. With that in mind, a modified version of DXDI 
was incorporated in 2015 into the Scottish Care Informa-
tion Diabetes Collaboration (SCI-Diabetes) platform, 
in which the complete diabetes record can be viewed 
by any National Health Service healthcare professional 
involved in a patient’s care.43 It should also be noted 
that, at the time of this writing, data on periodontal 
health are not accessible through the SCI-Diabetes 
platform. Second, though our simplified approach to 
periodontal assessment was designed to enable effec-
tive multidisciplinary screening and use of the DXDI 
in real-world clinical settings across the globe (without 
requiring detailed measurements of periodontal attach-
ment loss or the use of dental radiographic equipment 
that is not always readily available),2 validation of both 
through large-scale field studies is needed to help deter-
mine whether its sensitivity and specificity within diverse 
populations are clinically and epidemiologically accept-
able. Indeed, issues of interoperator and technical skill 
variability may pose limits on the widespread applicability 
of our simplified approach even as it serves to mitigate 
cost and access barriers. Further study is warranted to 
assess those potential limitations. Third, determining 
the real burden of periodontitis24 and other comorbid 
chronic diseases, such as chronic obstructive pulmonary 
disease and heart failure, in people with type 2 diabetes, 
raises the possibility that new domains could be further 
added to DXDI to assist in the management of patients 
with multimorbidity.18 20 35 44 45 In turn, the interrelation-
ships and complexities that impact health outcomes 
might be better understood and serve to inform guide-
lines and policy decisions around optimal allocation of 
scarce resources.2 17 30 How periodontitis impacts diverse 
populations in different geographical contexts and how 
treatment affects the complex natural history of diabetes 
and its complications remain to be determined.
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